Lorlatinib shows unprecedented success in advanced NSCLC

Release Date:


Which drug keeps lung cancer from progressing for over 5 years? Find out about this and more in today's PeerDirect Medical News Podcast.

Lorlatinib shows unprecedented success in advanced NSCLC

Title
Specialist Spotlight: Dr. Lofton on weight management and the on-label and off-label uses of GLP-1 agonists
Copyright
Release Date

flashback